Make an appointment

Book an Appointment

26 Nov. 2024

FDA approved tigecycline

The FDA has approved the use of the new antibacterial drug tigecycline for the treatment of complicated skin and soft tissue infections and complicated intra-abdominal infections in adult patients.

Read more

25 Nov. 2024

Long-term use of azithromycin in tracheostomy patients with chronic obstructive pulmonary disease

Long-term treatment with azithromycin in patients with severe COPD and outpatient tracheostomy is effective and safe and can reduce the incidence of COPD exacerbations, the number of hospitalizations and improve the quality of life.

Read more

24 Nov. 2024

The likelihood of developing febrile seizures and epilepsy after the administration of a combined vaccine for the prevention of diphtheria, tetanus, whooping cough, polio and Haemophilus influenzae infection type b

The combined vaccine that protects against pertussis increases the relative risk of developing febrile seizures on the day of the first and second vaccinations, while the absolute risk does not increase significantly.

Read more

23 Nov. 2024

The use of glucocorticosteroids increases the risk of infections in patients with juvenile idiopathic arthritis

In children with juvenile idiopathic arthritis (JIA) receiving oral glucocorticoids, the risk of developing infections is doubled.

Read more

22 Nov. 2024

A prospective randomized study comparing a short and a long course of intravenous antibacterial drugs in the treatment of acute pyelonephritis in children

Comparison of short and long-term courses of ceftriaxone iv in the treatment of acute pyelonephritis in children demonstrated the absence of the effect of the duration of parenteral administration of antibiotics on the incidence of changes scarring in the renal parenchyma.

Read more

21 Nov. 2024

Evaluation of the adequacy of antimicrobial treatment and the results of the bacteremia caused by Staphylococcus aureus: results of a study carried out in 9 European countries

Inadequate empirical antibiotic therapy is very common in Western Europe and is associated with infection caused by strains of MRSA Staphylococcus aureus.

Read more